NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/30/2024
Back to search
Official data from USPTO
EUROFINS BIOSKIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/30/2024
Trademark type
Combined
Nice classes
42, 44
Filing date
01/06/2022
Registration date
01/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/30/2024
Last transaction
01/30/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/01/2021
First use in commerce
11/01/2021
Drawing code
3
Owner type
11
Owner location
Co. Waterford, IE
Examiner
TARASCIO, MAUREEN J
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a design of a molecular model comprised of ten circles to the left of the word "EUROFINS", a vertical line, and the word "BIOSKIN".
Holders and representatives
Holders
EUROFINS SCIENTIFIC (IRELAND) LIMITED
EUROFINS SCIENTIFIC (IRELAND) LIMITED
Representatives
Joseph Sofer, Esq. IPSILON USA
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and industrial research in the physico-chemicalmicrobiologymolecular biologychemistrybiochemistryepidemiologicalmicrobiologicalmolecular biologicalpharmaceuticaldermatologicalgeneticbiotechnologicalimmunological fields; carrying out physicalchemicalphysical-chemicalbiochemicalbiologicalepidemiologicalmicrobiologicalmolecular biological or immunological analyses for scientific research purposesconducting scientific research in the nature of clinical studies in the pharmaceuticalmedical devicecosmeticpersonal care industries; scientific and industrial research in the pharmaceuticalmedical devicecosmeticpersonal care fields; development of methodsdevelopment and establishment of testing specifications and procedures in the field of physicalchemicalphysical-chemicalbiochemicalbiologicalepidemiologicalmicrobiologicalmolecular biologicalimmunological and biomolecular sciences; scientific research in the nature of preparing scientificmedical or industrial expert reports for scientists and engineers; technical researchconducting technical project studies in the physico-chemicalmicrobiologymolecular biologychemistrybiochemistryepidemiologicalmicrobiologicalmolecular biologicalpharmaceuticaldermatologicalgeneticbiotechnologicalimmunological fields; professional consultancy in the field of scientific and medical research; scientific and technological servicesscientific researchanalysisinspectionauditconsultingdesignengineeringdevelopment and laboratory testing services for others in the physico-chemicalmicrobiologymolecular biologychemistrybiochemistryepidemiologicalmicrobiologicalmolecular biologicalpharmaceuticaldermatologicalgeneticbiotechnologicalimmunological fields; scientific and technological servicesproduct developmentcommercialisationlife cycle managementimprovement of products manufactured by pharmaceuticalmedical deviceother science-oriented industries; consulting and advisory services related to analytical techniques for scientific research and product development processes; consulting and advisory services related to product developmentlife cycle managementimprovement of products manufactured by pharmaceuticalmedical device and other science-oriented industries; consumer product safety testing; product safety testing; testing of new products; consultancy relating to consumer product safety testing; design and testing of new products for others; scientific and technical research for others for pharmaceuticalsbiotech products and chemicals; development and research in the fields of pharmaceuticalsbiotech products; medical and scientific research in the nature of conducting clinical trials for others relating to medical devices and pharmaceuticals in the field of dermatology; medical and scientific research in the nature of conducting clinical trials for others in the fields of pharmaceuticalsmedical devicesproductscosmetics and personal care products; medical and scientific research services for ensuring safety and efficiency of pharmaceutical drugs and medical devices; pharmaceuticalbiopharmaceutical and clinical product research and development for others
Class 44
Medical servicesblood testingsalivaurinetissuehair and body fluid testing services; serological and urinary testing services for medicalepidemiological purposes; medical testing services relating to the diagnosis and treatment of disease in the field of epidemiology and genetics; medical clinic services; medical consultation services; hygienic and beauty care for human beings; collectionsampling and preservation of human bloodsalivaurinetissuehair and body fluids; medical testing for diagnostic and epidemiological purposesfor the diagnosis and treatment of disease; medical diagnostic testing in the field of anti-ageing medicine; medical information servicescarrying out medical biology test panels and interpretation of medical biology test results; allergy and immunology testing for medical purposes; medical testing services relating to the diagnosis and treatment of diseaseinfectious disease testing
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/30/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/28/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/27/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/09/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/09/2023
IUAF
USE AMENDMENT FILED
11/30/2023
EISU
TEAS STATEMENT OF USE RECEIVED
11/30/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/04/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/09/2023
PUBO
PUBLISHED FOR OPPOSITION
05/09/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/28/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/19/2022
GNRT
NON-FINAL ACTION E-MAILED
10/19/2022
CNRT
NON-FINAL ACTION WRITTEN
10/19/2022
DOCK
ASSIGNED TO EXAMINER
10/13/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/14/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/13/2022
NWAP
NEW APPLICATION ENTERED
01/10/2022
Continuous trademark protection
Get notified about every new filing that threatens EUROFINS BIOSKIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.